SLR Investment Q1 Earnings Call Highlights

Key Points

• Q1 results: SLR reported net investment income of $0.33 and net income of $0.31 per share with NAV of $18.16 at March 31; the company has ~$1.1 billion of debt, a net debt-to-equity ratio of 1.14x (within target), is investment‑grade rated, and declared a quarterly dividend of $0.31 per share.
• Portfolio and credit quality: The firm remains heavily weighted to specialty finance—about 85% of investments and 94.5% of the portfolio in first‑lien senior secured loans—with ~98% of the portfolio performing, no non‑accruals, a weighted average yield of 11.1%, and roughly $900 million of capital available to deploy.
• Strategic and governance moves: The board approved a permanent reduction in the performance incentive fee to 17.5% (from 20%), increased revolving commitments to $720 million, extended the $50 million buyback program for one year, and formed an AI committee while noting minimal direct software exposure (~2%).

SLR Investment NASDAQ: SLRC management said the company delivered a “solid start” to 2026 amid what it described as a more challenging backdrop for private credit, citing rising geopolitical uncertainty and heightened concern about how artificial intelligence could disrupt the economy and the asset class.

On the company’s first-quarter 2026 earnings call, Chairman and Co-CEO Michael Gross said the industry has faced “a speculative and often negative global conversation” and argued that SLR’s positioning in collateral-based specialty finance should help it navigate a recalibration of risk in direct lending. “We’ve been positioning the portfolio for this moment… for a long time,” Gross said.

Quarterly results and balance sheet

For the quarter ended March 31, 2026, SLR reported net investment income (NII) of $0.33 per share and net income of $0.31 per share. Gross attributed the sequential decline in NII primarily to three factors: the lagged impact of a 50-basis-point Federal Reserve rate cut in the fourth quarter of 2025 on floating-rate loans, a contraction in the comprehensive portfolio amid slower deal activity, and lower fee income.

Chief Financial Officer Shiraz Kajee said net asset value was $18.16 per share at March 31, down from $18.26 at December 31. He reported gross investment income of $49.3 million, down from $54.5 million in the prior quarter, and net expenses of $31.4 million compared with $32.9 million. NII totaled $17.9 million versus $21.6 million in the prior quarter. Below the line, Kajee said the company recorded net realized and unrealized losses of $0.7 million, compared with gains of $3.5 million in the fourth quarter of 2025.

Kajee said SLR had approximately $1.1 billion of debt outstanding and a net debt-to-equity ratio of 1.14x, within its stated target range of 0.9x to 1.25x. He also noted that the company is investment-grade rated by Fitch, Moody’s and DBRS, and that more than 40% of debt capital was unsecured as of quarter-end. Looking ahead, Kajee said the company has one 2026 maturity: $75 million of unsecured notes due in December.

After quarter-end, Kajee said the company increased revolving capacity by $25 million with a new lender, bringing total revolving commitments to $720 million from $695 million at quarter-end. He also said the board authorized a one-year extension of the company’s $50 million stock repurchase program.

Dividend and advisory fee changes

On May 5, the board declared a quarterly distribution of $0.31 per share, payable June 26 to shareholders of record as of June 12.

Kajee also said the board approved a “voluntary and permanent change” to the advisory agreement with SLR Capital Partners that reduces the performance-based incentive fee to 17.5% from 20%.

Asked on the call how the company and board arrived at the 17.5% figure, Gross said, “It wasn’t a long discussion,” and added that the change was “initiated by us, not the board.” Gross said the team does not manage the business around the hurdle rate, noting that “rates go up, rates go down” and that the hurdle “has been the right place to be.”

Portfolio activity and credit quality

Gross said SLR originated $242 million of new investments across its comprehensive portfolio during the quarter and received $360 million of repayments, for net repayments of $180 million and a quarter-end comprehensive portfolio of $3.2 billion. He said commercial finance strategies continued to drive originations, which management views as offering more attractive risk-adjusted returns in current markets.

Gross highlighted a continued portfolio tilt toward specialty finance. As of March 31, he said about 85% of investments were in senior secured specialty finance loans, and at quarter-end 94.5% of the comprehensive portfolio was in first-lien senior secured loans. He also said the company had “over $900 million available of capital to deploy” including available credit facility capacity at SSLP and its specialty finance portfolio companies.

Co-CEO Bruce Spohler said the environment reflects “the middle stages of a credit cycle,” with rising defaults and growing dispersion, and emphasized underwriting discipline and capital preservation. Spohler said that at fair value about 98% of the portfolio was in senior secured loans, including 94.5% in first lien, with 3.2% in second lien loans comprised entirely of asset-based loans with borrowing bases.

Spohler reported that weighted average asset-level yield was 11.1%, down from 11.6% in the prior quarter, due primarily to the lagged impact of lower base rates and reduced one-time income. He also said the portfolio’s weighted average investment risk rating was “under two” on SLR’s one-to-four internal scale and that nearly 98% of the portfolio is rated two or higher. Both Gross and Spohler emphasized credit metrics: 100% of investments at cost were performing, there were no non-accruals, and the watch list represented 2.2% of the portfolio.

When asked about the quarter’s high level of repayments and portfolio shrinkage, management said a significant portion of the $194 million of repayments in the asset-based lending (ABL) business reflected temporary, seasonal paydowns on revolving facilities rather than refinancings or exits. Management also described ABL documentation and borrowing-base controls as tools that can allow SLR to proactively reduce exposure if fundamentals deteriorate.

Strategy updates: ABL, equipment finance, life sciences, and cash flow lending

Spohler walked through SLR’s four investment verticals, highlighting an emphasis on specialty finance as a way to pursue what management called a “complexity premium” through collateral support and tighter documentation.

• Asset-based lending (ABL): Spohler said the ABL portfolio totaled just under $1.4 billion across 250 issuers, representing about 43% of the total portfolio. The company originated $77 million and had repayments of $194 million. Weighted average asset-level yield was 12.3%, down from 12.6%. Spohler said returns in ABL are meaningfully supported by churn and fee acceleration, noting close to 70% churn last year across ABL businesses, and he said management expects churn to revert toward historical levels over time and drive incremental fee income. He also said the advisor established a sourcing arrangement with a large U.S. commercial bank to expand ABL origination reach, and that SLR is evaluating other partnerships as well as potential portfolio or ABL business acquisitions.
• Equipment finance: Spohler said the equipment finance portfolio totaled just under $1.1 billion, about a third of the total portfolio, across 580 borrowers. The company originated $122 million and had roughly $126 million of repayments. Yield was 10.2% versus 10.9% in the prior quarter. He said the pipeline has expanded and that borrowers are seeking to extend leases rather than buy new equipment at higher “tariff-adjusted” prices.
• Life sciences: The life sciences portfolio stood at just over $180 million (close to 6% of the portfolio), down from a prior peak of 15%, as Spohler cited competitive pressures and what he called degraded credit discipline in the market. He said life sciences historically averaged 22% of quarterly gross comprehensive income since 2020 but contributed 13.5% in the first quarter, with one-time life sciences fees around 1% of gross investment income versus a historical average of 3.5%. Spohler said the pipeline has “picked up materially” in 2026 and that the advisor hired three experienced professionals to broaden origination reach.
• Cash flow lending and SSLP: Spohler reiterated a focus on upper mid-market, sponsor-backed lending, particularly in healthcare, while selectively investing in business and financial services. The cash flow portfolio was $480 million across 28 borrowers, including loans in SSLP, with approximately 2% allocated to software and a weighted average loan-to-value of 38%. Spohler said interest coverage was 2.2x, up from 2.0x in the prior quarter. During Q1, the company invested $43 million and had about $40 million of repayments in first-lien cash flow loans, with only one of 12 investments to a new borrower. For SSLP, Spohler said SLR invested $9.8 million and had $3.4 million of repayments; net leverage was just under 1x and Q1 income was $1.5 million, equating to an annualized yield of about 12.25% versus 9.25% in the fourth quarter.

On AI-related risk, Gross said SLR has “a lack of software exposure,” with direct software exposure at about 2% of fair value as of March 31, and said the company formed an artificial intelligence investment committee to evaluate both new opportunities and existing portfolio risk from AI. Gross also said SLR is implementing AI internally to assist with borrower-base and covenant analysis, streamlining workflows, and improving legal docket reviews.

In the Q&A, management said a rebound in fee income tied to churn in ABL and life sciences would likely take “a few quarters” to develop, describing a typical life cycle in which loans with contractual durations of five or six years often repay in about two years. Gross said management set the dividend at a level it expects to “exceed in the near term” while pursuing initiatives intended to grow earnings over time.

About SLR Investment NASDAQ: SLRC

SLR Investment Corp. NASDAQ: SLRC is a closed‐end, externally managed business development company that provides customized debt and equity financing solutions to middle‐market companies. The firm seeks to generate current income and capital appreciation by investing primarily in senior secured loans, second lien financings, mezzanine debt and equity co‐investments. Its flexible capital approach allows it to structure financing across the capital structure to address a range of sponsor‐backed transactions.

SLR Investment Corp.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.